Ribosomal protein L17, RpL17, is an inhibitor of vascular smooth muscle growth and carotid intima formation

Circulation

Volumn 126, Issue 20, 2012, Pages 2418-2427

  Smolock, Elaine M ^a   Korshunov, Vyacheslav A ^a   Glazko, Galina ^a   Qiu, Xing ^a   Gerloff, Janice ^a   Berk, Bradford C ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

bioinformatics; cell growth; proliferation; ribosomal proteins; vascular smooth muscle

Indexed keywords

RIBOSOMAL PROTEIN L17; RIBOSOME PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL WALL THICKNESS; ARTICLE; CAROTID ARTERY; CAROTID ARTERY LIGATION; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; GENOME ANALYSIS; MICROARRAY ANALYSIS; MOUSE; MUSCLE GROWTH; NEOINTIMA; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; UPREGULATION; VASCULAR SMOOTH MUSCLE;

ANIMALS; CAROTID ARTERIES; CELL CYCLE; CELL PROLIFERATION; CELLS, CULTURED; COMPUTATIONAL BIOLOGY; G0 PHASE; G1 PHASE; HUMANS; MALE; MICE; MICE, INBRED C3H; MICE, INBRED STRAINS; MICROARRAY ANALYSIS; MUSCLE, SMOOTH, VASCULAR; RATS; RIBOSOMAL PROTEINS; S PHASE; TUNICA INTIMA; TUNICA MEDIA;

EID: 84869225507     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.112.125971     Document Type: Article

References (49)

1. Lusis AJ, Pajukanta P. A treasure trove for lipoprotein biology. Nat Genet. 2008;40:129-130. (Pubitemid 351171408)
2. Thongboonkerd V. Genomics, proteomics and integrative "omics" in hypertension research. Curr Opin Nephrol Hypertens. 2005;14:133-139. (Pubitemid 40396866)
3. Schadt EE, Lamb J, Yang X, Zhu J, Edwards S, Guhathakurta D, Sieberts SK, Monks S, Reitman M, Zhang C, Lum PY, Leonardson A, Thieringer R, Metzger JM, Yang L, Castle J, Zhu H, Kash SF, Drake TA, Sachs A, Lusis AJ. An integrative genomics approach to infer causal associations between gene expression and disease. Nat Genet. 2005;37:710-717. (Pubitemid 41754887)
4. Mehrabian M, Allayee H, Stockton J, Lum PY, Drake TA, Castellani LW, Suh M, Armour C, Edwards S, Lamb J, Lusis AJ, Schadt EE. Integrating genotypic and expression data in a segregating mouse population to identify 5-lipoxygenase as a susceptibility gene for obesity and bone traits. Nat Genet. 2005;37:1224-1233. (Pubitemid 41568705)
5. Seda O, Tremblay J, Gaudet D, Brunelle PL, Gurau A, Merlo E, Pilote L, Orlov SN, Boulva F, Petrovich M, Kotchen TA, Cowley AW Jr, Hamet P. Systematic, genome-wide, sex-specific linkage of cardiovascular traits in French Canadians. Hypertension. 2008;51:1156-1162. (Pubitemid 351398964)
6. Allan PL, Mowbray PI, Lee AJ, Fowkes FG. Relationship between carotid intima-media thickness and symptomatic and asymptomatic peripheral arterial disease. The Edinburgh Artery Study. Stroke. 1997;28:348-353. (Pubitemid 27097003)
7. Davis PH, Dawson JD, Riley WA, Lauer RM. Carotid intimal-medial thickness is related to cardiovascular risk factors measured from childhood through middle age: The Muscatine Study. Circulation. 2001; 104:2815-2819. (Pubitemid 33126656)
8. Cheng Y, Austin SC, Rocca B, Koller BH, Coffman TM, Grosser T, Lawson JA, FitzGerald GA. Role of prostacyclin in the cardiovascular response to thromboxane a2. Science. 2002;296:539-541. (Pubitemid 34408674)
9. Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation. 2007;115:459-467. (Pubitemid 46184197)
10. Lorenz MW, Karbstein P, Markus HS, Sitzer M. High-sensitivity c-reactive protein is not associated with carotid intima-media progression: the carotid atherosclerosis progression study. Stroke. 2007;38:1774-1779. (Pubitemid 46847246)
11. Korshunov VA, Berk BC. Flow-induced vascular remodeling in the mouse: a model for carotid intima-media thickening. Arterioscler Thromb Vasc Biol. 2003;23:2185-2191. (Pubitemid 37532318)
12. Korshunov VA, Berk BC. Strain-dependent vascular remodeling: The "glagov phenomenon" is genetically determined. Circulation. 2004;110:220-226. (Pubitemid 38924591)
13. Korshunov VA, Nikonenko TA, Tkachuk VA, Brooks A, Berk BC. Interleukin-18 and macrophage migration inhibitory factor are associated with increased carotid intima-media thickening. Arterioscler Thromb Vasc Biol. 2006;26:295-300. (Pubitemid 43732190)
14. Chen C, Korshunov VA, Massett MP, Yan C, Berk BC. Impaired vas-orelaxation in inbred mice is associated with alterations in both nitric oxide and super oxide pathways. J Vasc Res. 2007;44:504-512. (Pubitemid 350022325)
15. Korshunov VA, Berk BC. Genetic modifier loci linked to intima formation induced by low flow in the mouse carotid. Arterioscler Thromb Vasc Biol. 2009;29:47-53.
16. Shi W, Wang NJ, Shih DM, Sun VZ, Wang X, Lusis AJ. Determinants of atherosclerosis susceptibility in the c3h and c57bl/6 mouse model: evidence for involvement of endothelial cells but not blood cells or cholesterol metabolism. Circ Res. 2000;86:1078-1084. (Pubitemid 30367867)
17. Lutgens E, Faber B, Schapira K, Evelo CT, van Haaften R, Heeneman S, Cleutjens KB, Bijnens AP, Beckers L, Porter JG, Mackay CR, Rennert P, Bailly V, Jarpe M, Dolinski B, Koteliansky V, de Fougerolles T, Daemen MJ. Gene profiling in atherosclerosis reveals a key role for small inducible cytokines: validation using a novel monocyte chemoattractant protein monoclonal antibody. Circulation. 2005;111:3443-3452. (Pubitemid 40923398)
18. Yuan Z, Pei H, Roberts DJ, Zhang Z, Rowlan JS, Matsumoto AH, Shi W. Quantitative trait locus analysis of neointimal formation in an intercross between c57bl/6 and c3h/hej apolipoprotein e-deficient mice. Circ Car-diovasc Genet. 2009;2:220-228.
19. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C, Maechler M, Rossini AJ, Sawitzki G, Smith C, Smyth G, Tierney L, Yang JY, Zhang J. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004;5:R80.
20. Team RDC. A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2006.
21. Gordon A, Glazko G, Qiu X, Yakovlev AY. Control of the mean number of false discoveries, Bonferroni, and stability of multiple testing. Ann Appl Stat. 2007;1:179-190.
22. Kanehisa M, Goto S. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 2000;28:27-30. (Pubitemid 30047706)
23. Kong SW, Pu WT, Park PJ. A multivariate approach for integrating genome-wide expression data and biological knowledge. Bioinformatics. 2006;22:2373-2380. (Pubitemid 44566966)
24. Korshunov VA, Berk BC. Smooth muscle apoptosis and vascular remodeling. Curr Opin Hematol. 2008;15:250-254. (Pubitemid 351507578)
25. Chiang HY, Korshunov VA, Serour A, Shi F, Sottile J. Fibronectin is an important regulator of flow-induced vascular remodeling. Arterioscler Thromb Vasc Biol. 2009;29:1074-1079.
26. Satoh K, Matoba T, Suzuki J, O'Dell MR, Nigro P, Cui Z, Mohan A, Pan S, Li L, Jin ZG, Yan C, Abe J, Berk BC. Cyclophilin a mediates vascular remodeling by promoting inflammation and vascular smooth muscle cell proliferation. Circulation. 2008;117:3088-3098.
27. Nagel DJ, Aizawa T, Jeon KI, Liu W, Mohan A, Wei H, Miano JM, Florio VA, Gao P, Korshunov VA, Berk BC, Yan C. Role of nuclear Ca2+/calmodulin-stimulated phosphodiesterase 1A in vascular smooth muscle cell growth and survival. Circ Res. 2006;98:777-784.
28. Neumann F, Krawinkel U. Constitutive expression of human ribosomal protein L7 arrests the cell cycle in G1 and induces apoptosis in Jurkat T-lymphoma cells. Exp Cell Res. 1997;230:252-261. (Pubitemid 27190645)
29. Naora H, Takai I, Adachi M. Altered cellular responses by varying expression of a ribosomal protein gene: sequential coordination of enhancement and suppression of ribosomal protein s3a gene expression induces apoptosis. J Cell Biol. 1998;141:741-753. (Pubitemid 28217918)
30. Yang X, Peterson L, Thieringer R, Deignan JL, Wang X, Zhu J, Wang S, Zhong H, Stepaniants S, Beaulaurier J, Wang IM, Rosa R, Cumiskey AM, Luo JM, Luo Q, Shah K, Xiao J, Nickle D, Plump A, Schadt EE, Lusis AJ, Lum PY. Identification and validation of genes affecting aortic lesions in mice. J Clin Invest. 2010;120:2414-2422.
31. Doran AC, Lehtinen AB, Meller N, Lipinski MJ, Slayton RP, Oldham SN, Skaflen MD, Yeboah J, Rich SS, Bowden DW, McNamara CA. Id3 is a novel atheroprotective factor containing a functionally significant single-nucleotide polymorphism associated with intima-media thickness in humans. Circ Res. 2010;106:1303-1311.
32. Harmon KJ, Couper LL, Lindner V. Strain-dependent vascular remodeling phenotypes in inbred mice. Am J Pathol. 2000;156:1741-1748. (Pubitemid 30646711)
33. Wool IG. Extraribosomal functions of ribosomal proteins. Trends Biochem Sci. 1996;21:164-165. (Pubitemid 26142565)
34. Lindstrom MS. Emerging functions of ribosomal proteins in gene-specific transcription and translation. Biochem Biophys Res Commun. 2009;379:167-170.
35. Warner J, McIntosh K. How common are extraribosomal functions of ribosomal proteins? Mol Cell. 2009;34:3-11.
36. Ebert BL, Pretz J, Bosco J, Chang CY, Tamayo P, Galili N, Raza A, Root DE, Attar E, Ellis SR, Golub TR. Identification of RPS14 as a 5q-syndrome gene by RNA interference screen. Nature. 2008;451:335-339.
37. Farrar JE, Nater M, Caywood E, McDevitt MA, Kowalski J, Takemoto CM, Talbot CC Jr, Meltzer P, Esposito D, Beggs AH, Schneider HE, Grabowska A, Ball SE, Niewiadomska E, Sieff CA, Vlachos A, Atsi-daftos E, Ellis SR, Lipton JM, Gazda HT, Arceci RJ. Abnormalities of the large ribosomal subunit protein, Rpl35a, in Diamond-Blackfan anemia. Blood. 2008;112:1582-1592.
38. Kobayashi T, Sasaki Y, Oshima Y, Yamamoto H, Mita H, Suzuki H, Toyota M, Tokino T, Itoh F, Imai K, Shinomura Y. Activation of the ribosomal protein l13 gene in human gastrointestinal cancer. Int J Mol Med. 2006;18:161-170.
39. Lai MD, Xu J. Ribosomal proteins and colorectal cancer. Curr Genomics. 2007;8:43-49. (Pubitemid 46488274)
40. Sim EU, Ang CH, Ng CC, Lee CW, Narayanan K. Differential expression of a subset of ribosomal protein genes in cell lines derived from human nasopharyngeal epithelium. J Hum Genet. 2010;55:118-120.
41. Bee A, Brewer D, Beesley C, Dodson A, Forootan S, Dickinson T, Gerard P, Lane B, Yao S, Cooper CS, Djamgoz MB, Gosden CM, Ke Y, Foster CS. Sirna knockdown of ribosomal protein gene rpl19 abrogates the aggressive phenotype of human prostate cancer. PLoS One. 2011;6: e22672.
42. Dai MS, Zeng SX, Jin Y, Sun XX, David L, Lu H. Ribosomal protein L23 activates p53 by inhibiting MDM2 function in response to ribosomal perturbation but not to translation inhibition. Mol Cell Biol. 2004;24:7654-7668. (Pubitemid 39121491)
43. Lohrum MA, Ludwig RL, Kubbutat MH, Hanlon M, Vousden KH. Regulation of HDM2 activity by the ribosomal protein L11. Cancer Cell. 2003;3:577-587. (Pubitemid 36808652)
44. Zhang Y, Wolf GW, Bhat K, Jin A, Allio T, Burkhart WA, Xiong Y. Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway. Mol Cell Biol. 2003;23:8902-8912. (Pubitemid 37433388)
45. Takagi M, Absalon MJ, McLure KG, Kastan MB. Regulation of p53 translation and induction after DNA damage by ribosomal protein l26 and nucleolin. Cell. 2005;123:49-63. (Pubitemid 41414528)
46. Horn HF, Vousden KH. Cooperation between the ribosomal proteins L5 and L11 in the p53 pathway. Oncogene. 2008;27:5774-5784.
47. Bhat KP, Itahana K, Jin A, Zhang Y. Essential role of ribosomal protein L11 in mediating growth inhibition-induced p53 activation. EMBO J. 2004;23:2402-2412. (Pubitemid 38954847)
48. Tanaka K, Sata M, Hirata Y, Nagai R. Diverse contribution of bone marrow cells to neointimal hyperplasia after mechanical vascular injuries. Circ Res. 2003;93:783-790. (Pubitemid 37288674)
49. Filip AM, Klug J, Cayli S, Frohlich S, Henke T, Lacher P, Eickhoff R, Bulau P, Linder M, Carlsson-Skwirut C, Leng L, Bucala R, Kraemer S, Bernhagen J, Meinhardt A. Ribosomal protein S19 interacts with macro-phage migration inhibitory factor and attenuates its pro-inflammatory function. J Biol Chem. 2009;284:7977-7985.